Vimentin Is a Novel Anti-Cancer Therapeutic Target; Insights from In Vitro and In Vivo Mice Xenograft Studies

Guy Lahat, Quan-Sheng Zhu, Kai-Lieh Huang et al. · 2010

Read Vimentin Is a Novel Anti-Cancer Therapeutic Target; Insights from In Vitro and In Vivo Mice Xenograft Studies by Guy Lahat, Quan-Sheng Zhu, Kai-Lieh Huang et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010105.txt.

Description

The authors were Guy Lahat, Quan-Sheng Zhu, Kai-Lieh Huang, and others. Their 2010 PLOS ONE study named vimentin as a possible cancer drug target. Vimentin is a structural filament found in many connective tissue cells. In active cells it also helps with adhesion, movement, survival, and signaling through constant rebuilding.

The team drew evidence from lab cell work and mouse tumors grown from human tissue. Soft tissue sarcomas were among the cancers in view. If vimentin can be attacked safely, cancers that depend on it might gain a new treatment option.

Catalog record

CREATORGuy Lahat, Quan-Sheng Zhu, Kai-Lieh Huang et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE81 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010105

Browse the full library · About the Tower of Babel